DMCAF

 
Ordinary Shares International Reporting
OTCQB
Verified Company Profile 5/01/2017
Contact Info
  • c.o DiaMedica USA Inc.
  • 2 Carlson Pkwy, Ste 165
  • Minneapolis, MN 55447

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Interim Financial Report
CIK 0001401040
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Manitoba, Canada
Year of Inc. 2000
Employees Not Available
Company Officers/Contacts
Rick John Pauls President, CEO
Paul Papi VP, Bus. Dev. & Corp. Rel.
David Gurvey VP, Fin.
Todd Verdoorn CSO
Donna Husemoller Corporate Controller
Company Directors
Richard Dal Pilnik Chairman
Michael Giuffre
James Parsons
Zhenyu "Jerry" Xiao
Company Notes
  • Formerly=Diamedica, Inc. until 12-2016
Service Providers
Accounting/Auditing Firm
KPMG LLP
333 Bay Street Suite 4600
Bay Adelaide Centre
Toronto, ONT, M5H 2S5
Canada

Legal Counsel
Pushor Mitchell LLP
301-1665 Ellis Street
Kelowna, BC, V1Y 2B3
Canada

Investor Relations Firm
Not Available
DMCAF Security Details
Share Structure
Market Value1 $26,922,147 a/o Sep 20, 2017
Authorized Shares Unlimited a/o Jun 29, 2016
Outstanding Shares 121,107,275 a/o Apr 30, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Computershare
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
DMA - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 600 (0%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security